
Dormant ‘sleeper’ cells (red) and active cancer cells (green)
Breast cancer medicines may force some cancer cells into ‘sleeper mode’, allowing them to potentially come back to life years after initial treatment.
These are the early-stage findings from scientists at Imperial College London, who studied human breast cancer cells in the laboratory.
If we can unlock the secrets of these dormant cells, we may be able to find a way of preventing cancer coming back Dr Luca MagnaniStudy author
The team, who studied a group of breast cancer drugs called hormone treatments, say their research opens avenues for finding ways of keeping the cancer cells dormant for longer, or even potentially finding a way of awakening the cells so they can then be killed by the treatment.
Dr Luca Magnani, lead author of the study from Imperial’s Department of Surgery and Cancer said: “For a long time scientists have debated whether hormone therapies – which are a very effective treatment and save millions of lives – work by killing breast cancer cells or whether the drugs flip them into a dormant ‘sleeper’ state.
“This is an important question as hormone treatments are used on the majority of breast cancers. Our findings suggest the drugs may actually kill some cells and switch others into this sleeper state. If we can unlock the secrets of these dormant cells, we may be able to find a way of preventing cancer coming back, either by holding the cells in permanent sleep mode, or be waking them up and killing them.”
Preventing cancer relapse
In the study, published in the journal Nature Communications and funded by Cancer Research UK and the NIHR Imperial Biomedical Research Centre, the team studied around 50,000 human breast cancer single cells in the lab, and found that treating them with hormone treatment exposed a small proportion of them as being in a dormant state.
The team say the ‘sleeper cells’ may also provide clues as to why some breast cancer cells become resistant to treatment, causing a patient’s drugs to stop working, and their cancer to return.
Hormone therapies are used to treat a type of breast cancer called oestrogen-receptor positive. These make up over 70 per cent of all breast cancers, and are fuelled by the hormone oestrogen.
These cancers are usually treated with surgery to remove the tumour, followed by a course of targeted hormone therapy – usually either aromatase inhibitors or tamoxifen, which target oestrogen receptors.
However, around 30 per cent of breast cancer patients taking hormone therapies see their cancer eventually return – sometimes as long as 20 years after treatment. This returning cancer is usually metastatic, meaning it has spread around the body, and the tumours are often now resistant to medication.
Sleeper cells move around the body
Previous work by the same team has investigated why breast cancer cells become resistant to hormone treatment, with findings suggesting cells can make their own ‘fuel’, allowing them to avoid being ‘starved’ by cancer treatment.
Our experiments suggest these sleeper cells are more likely to travel around the body Dr Sung Pil Hong Study author
This new research provides another piece in the puzzle, explained Dr Iros Barozzi, co-author of the study, also from the Department of Surgery and Cancer: ‘These sleeper cells seem to be an intermediate stage to the cells becoming resistant to the cancer drugs. The findings also suggest the drugs actually trigger the cancer cells to enter this sleeper state.”
The research also revealed cells in this dormant sleeper state were more likely to spread around the body, explained Dr Sung Pil Hong, study co-author from Imperial: “Our experiments suggest these sleeper cells are more likely to travel around the body. They could then ‘awaken’ once in other organs of the body, and cause secondary cancers. However, we still don’t know how these cells switch themselves into sleep mode – and what would cause them to wake up. These are questions that need to be addressed with further research.”
The team added that hormone therapies remain one of the most effective treatments against breast cancer, and that further patient research will explore whether taking hormone therapies for longer after initial cancer treatment could prevent cancer cells from waking from their sleeping state.
Dr Rachel Shaw from Cancer Research UK, said: “Although treatments for breast cancer are usually successful, cancer returns for some women, often bringing with it a poorer prognosis. Figuring out why breast cancer sometimes comes back is essential to help us develop better treatments and prevent this from happening. This study highlights a key route researchers can now explore to tackle ‘sleeping’ cancer cells that can wake up years after treatment, which could potentially save the lives of many more women with the disease.”
Learn more: Breast cancer can form ‘sleeper cells’ after drug treatment
The Latest on: Breast cancer
[google_news title=”” keyword=”breast cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Breast cancer
- Breast Cancer Treatment Market Growth Rate or CAGR is Expected 8.6% in the Coming Year 2027 – Novartis International AG, Pfizer Inc., and Sanofi S.Aon March 30, 2023 at 2:34 am
MarkNtel Advisors introduces the most recent edition of the Breast Cancer Treatment Market, which includes an analysis of numerous market growth factors.
- Research Further Associates Widespread Atrazine Exposure to Breast Canceron March 29, 2023 at 9:06 pm
(Beyond Pesticides, March 30, 2023) A study published in Ecotoxicology and Environmental Safety finds that the commonly used herbicide, atrazine, promotes breast cancer development through suppression ...
- Jersey Mike’s Subs making donations to help breast cancer patientson March 29, 2023 at 4:41 pm
Here on the Coast, the sub shop is making donations to help breast cancer patients. Jersey Mike’s Subs in Gulfport and D’Iberville are donating 100% of sales to Carter’s Champions Breast Cancer Fund ...
- Birth Control and Breast Cancer: Progestin-Only Methods Carry Similar Risk to Combination Optionson March 29, 2023 at 3:20 pm
New research found that progestin-only birth control provides the same risk of breast cancer as combination birth control containing estrogen. Researchers note that this risk is still very small, and ...
- Surgeons can play an important role in reducing breast cancer disparitieson March 29, 2023 at 2:34 pm
Surgeons can play a key role in reducing breast cancer disparities by increasing their awareness of where disparities exist and having open conversations with their patients about their needs to ...
- Breast Cancer Rowing Team From Annapolis Will Compete In New Zealandon March 29, 2023 at 10:15 am
The Annapolis Dragon Boat Club will visit New Zealand in April for a rowing competition hosted by the International Breast Cancer Paddlers' Commission, Chesapeake Bay Magazine reported. These local ...
- How California mom beat breast cancer, became an advocate for Latinas: ‘I can give them hope’on March 29, 2023 at 9:30 am
Claudia Olsen shares her journey as a cancer survivor in the second installment of The Tribune’s Diversity Storytelling Project.
- Team of survivors representing PNW at International Breast Cancer Dragon Boat Festivalon March 29, 2023 at 7:30 am
The team called “Pacific Northwest Pink Lemonade” is comprised of 26 women ranging from 40 to over 80 years old.
- New breast cancer gene can predict likelihood of hereditary disease, study findson March 29, 2023 at 5:32 am
In what researchers describe as a landmark study, mutations in the ATRIP gene have been found to predict the likelihood of women developing hereditary breast cancer.
- The Story Behind a Birth Control Breast Cancer Scareon March 29, 2023 at 3:01 am
Recently, a new study about birth control gave me a scare. But first... I was catching up on news last week when I saw a headline that grabbed my attention. It was something along the lines of this: ...
via Bing News